These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2850925)

  • 21. Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of beta-adrenoceptors but not functional downregulation.
    Pilc A; Vetulani J
    Neuropharmacology; 1990 May; 29(5):469-73. PubMed ID: 1972550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic electroconvulsive shock on the expression of beta-adrenergic receptors in rat brain: immunological study.
    Seo DO; Shin CY; Seung CH; Han SY; Ko KH
    Biochem Mol Biol Int; 1999 Feb; 47(2):195-203. PubMed ID: 10205664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats.
    Green AR; Johnson P; Nimgaonkar VL
    Br J Pharmacol; 1983 Sep; 80(1):173-7. PubMed ID: 6228277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of repeated treatment with electroconvulsive shock (ECS) on serotonin receptor density and turnover in the rat cerebral cortex.
    Nowak G; Dulinski J
    Pharmacol Biochem Behav; 1991 Mar; 38(3):691-4. PubMed ID: 2068209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals.
    Gandolfi O; Barbaccia ML; Costa E
    Eur J Pharmacol; 1984 Apr; 100(2):233-7. PubMed ID: 6329776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.
    Mousseau DD; McManus DJ; Baker GB; Juorio AV; Dewhurst WG; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Feb; 13(1):3-13. PubMed ID: 8384528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of serotonin neurotransmission by antidepressant drugs and electroconvulsive shock: the fall and rise of serotonin receptors.
    Kellar KJ; Stockmeier CA; Gomez JM
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():138-45. PubMed ID: 2984881
    [No Abstract]   [Full Text] [Related]  

  • 29. Lithium does not prevent ECS-induced decreases in beta-adrenergic receptors.
    Birmaher B; Lerer B; Belmaker RH
    Psychopharmacology (Berl); 1982; 78(2):190-1. PubMed ID: 6294719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical beta-adrenoceptors.
    Belmaker RH; Lerer B; Bannet J; Birmaher B
    J Pharm Pharmacol; 1982 Apr; 34(4):275. PubMed ID: 6124609
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of serotonergic input in the down-regulation of beta-adrenoceptors following long-term clorgyline treatment.
    Aulakh CS; Cohen RM; Dauphin MM; McLellan CA; Murphy DL
    Eur J Pharmacol; 1988 Oct; 156(1):63-70. PubMed ID: 2463178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in serotonin2 receptor density in rat cerebral cortex slices by stimulation of beta-adrenergic receptors.
    Scott JA; Crews FT
    Biochem Pharmacol; 1985 May; 34(9):1585-8. PubMed ID: 2986651
    [No Abstract]   [Full Text] [Related]  

  • 33. 5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and desipramine-induced down-regulation of cortical beta adrenoceptors: a re-evaluation.
    Manier DH; Gillespie DD; Sulser F
    Biochem Pharmacol; 1987 Oct; 36(19):3308-10. PubMed ID: 2822049
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of electroconvulsive shock on 5-HT2 and alpha 1-adrenoceptors and phosphoinositide signalling system in rat brain.
    Pandey GN; Pandey SC; Isaac L; Davis JM
    Eur J Pharmacol; 1992 Aug; 226(4):303-10. PubMed ID: 1327845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of beta-adrenergic-agonist binding to rat adipocyte membranes. Evidence that (+/-)-[3H]hydroxybenzylisoproterenol interacts selectively with the adipocyte beta-adrenergic receptors.
    Giudicelli Y; Lacasa D; Agli B
    Biochim Biophys Acta; 1982 Mar; 715(1):105-15. PubMed ID: 6122470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities.
    Dumbrille-Ross A; Tang SW
    Psychiatry Res; 1983 Jul; 9(3):207-15. PubMed ID: 6312480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of 125I-iodohydroxybenzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta-adrenoceptors.
    Willcocks AL; Nahorski SR
    Biochem Pharmacol; 1983 Nov; 32(22):3311-9. PubMed ID: 6316978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons.
    Brunello N; Barbaccia ML; Chuang DM; Costa E
    Neuropharmacology; 1982 Nov; 21(11):1145-9. PubMed ID: 6294548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock.
    Heal DJ; Bristow LM; Hurst EM; Elliott JM; Buckett WR
    Br J Pharmacol; 1989 May; 97(1):111-8. PubMed ID: 2541853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.